Skip to main content
Top
Published in: BMC Gastroenterology 1/2024

Open Access 01-12-2024 | Gastric Cancer | Research

The pertinence of gastric cancer and interleukin 10–819 single nucleotide polymorphisms: a meta-analysis and systematic review

Authors: Qianqian Mao, Yanwen Liu, Xi Chen, Cheng Jiang Liu

Published in: BMC Gastroenterology | Issue 1/2024

Login to get access

Abstract

Purpose

Cytokines regulate the interaction between the immune system and malignant tumors. Among them, interleukin-10 (IL-10) is a multifunctional anti-inflammatory cytokine mainly produced by immune cells. The correlation between gastric cancer and T/C single nucleotide polymorphism (SNP) of interleukin-10 (IL-10) promoter−819(rs1800871)was opaque and remained to be determined. We aim to explore the pertinence of gastric cancer and SNP of interleukin 10–819 by meta-analysis via five statistical models.

Methods

Databases including PubMed, Cochrane Library, Embase, the Scopus, and Google Scholars were comprehensively retrieved for the eligible studies on the related topic from inception to March 2022. Odds ratios (ORs) were generated for dichotomous variants by meta-analysis in each model via STATA 17.0 MP. The statistical models comprised recessive model, over-dominant model, allele model, co-dominant model and dominant model. Subgroup analysis was performed to investigate the difference across races as well as the source of heterogeneity if necessary.

Results

Eventually a total of 15 articles reporting 7779 patients were enrolled in our study. There were 2383 patients and 5396 controls, collectively. There was no correlation between gastric cancer and IL-10 819 in recessive model, co-dominant model or dominant model, and subgroup analysis showed that Asian, Latin American and Caucasian had no correlation with the risk of gastric cancer. In the allelic model, there was significant correlation between gastric cancer and IL-10 819 (OR = 3.96%, 95%CI: 3.28 to 3.78). In the over-dominant model, there is no correlation between gastric cancer and IL-10 819, but subgroup analysis uncovered significant vulnerability of Asian people with regard to gastric cancer.

Conclusions

In our study, both Asians, Latin Americans, and Europeans showed an increased risk of gastric cancer in the allelic model, whereas only Asians showed significant susceptibility in the super dominant model. Of course, more large cohort studies are needed to confirm our results.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wang FH, Zhang XT, Li YF et al. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond). 2021 Aug;41(8):747-795. CrossRefPubMed Wang FH, Zhang XT, Li YF et al. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond). 2021 Aug;41(8):747-795. CrossRefPubMed
2.
go back to reference Suh YS, Yang HK. Screening and Early Detection of Gastric Cancer: East Versus West. Surg Clin North Am. 2015 Oct;95(5):1053-66. doi: 10.1016/j.suc.2015.05.012. Epub 2015 Jul 29. Suh YS, Yang HK. Screening and Early Detection of Gastric Cancer: East Versus West. Surg Clin North Am. 2015 Oct;95(5):1053-66. doi: 10.1016/j.suc.2015.05.012. Epub 2015 Jul 29. CrossRefPubMed Suh YS, Yang HK. Screening and Early Detection of Gastric Cancer: East Versus West. Surg Clin North Am. 2015 Oct;95(5):1053-66. doi: 10.1016/j.suc.2015.05.012. Epub 2015 Jul 29. Suh YS, Yang HK. Screening and Early Detection of Gastric Cancer: East Versus West. Surg Clin North Am. 2015 Oct;95(5):1053-66. doi: 10.1016/j.suc.2015.05.012. Epub 2015 Jul 29. CrossRefPubMed
3.
go back to reference Tannapfel A. Gegenwärtiger Stand Der Molekularpathologie Des Magenkarzinoms. Pathologe. 2001;22:37–43.CrossRefPubMed Tannapfel A. Gegenwärtiger Stand Der Molekularpathologie Des Magenkarzinoms. Pathologe. 2001;22:37–43.CrossRefPubMed
4.
go back to reference Azizzadeh-Roodpish S, Garzon M, Mainali S. Classifying single nucleotide polymorphisms in humans. Mol Genet Genomics. 2021;296(5):1161–73.CrossRefPubMed Azizzadeh-Roodpish S, Garzon M, Mainali S. Classifying single nucleotide polymorphisms in humans. Mol Genet Genomics. 2021;296(5):1161–73.CrossRefPubMed
5.
go back to reference Yasui W, Sentani K, Motoshita J, et al. Molecular pathobiology of gastric cancer. Scand J Surg. 2006;95(4):225–31.CrossRefPubMed Yasui W, Sentani K, Motoshita J, et al. Molecular pathobiology of gastric cancer. Scand J Surg. 2006;95(4):225–31.CrossRefPubMed
6.
go back to reference Zheng X, Wu Y, Bi J, et al. The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy. Cell Mol Immunol. 2022;19(2):192–209.CrossRefPubMedPubMedCentral Zheng X, Wu Y, Bi J, et al. The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy. Cell Mol Immunol. 2022;19(2):192–209.CrossRefPubMedPubMedCentral
7.
go back to reference Seruga B, Zhang H, Bernstein LJ, et al. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008;8(11):887–99.CrossRefPubMed Seruga B, Zhang H, Bernstein LJ, et al. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008;8(11):887–99.CrossRefPubMed
8.
go back to reference Trifunović J, Miller L, Debeljak Ž, et al. Pathologic patterns of interleukin 10 expression–a review. Biochem Med (Zagreb). 2015;25(1):36–48.CrossRefPubMed Trifunović J, Miller L, Debeljak Ž, et al. Pathologic patterns of interleukin 10 expression–a review. Biochem Med (Zagreb). 2015;25(1):36–48.CrossRefPubMed
9.
go back to reference Yu Z, Liu Q, Huang C, et al. The interleukin 10 -819 C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls. OMICS. 2013;17(4):200–14.CrossRefPubMedPubMedCentral Yu Z, Liu Q, Huang C, et al. The interleukin 10 -819 C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls. OMICS. 2013;17(4):200–14.CrossRefPubMedPubMedCentral
10.
go back to reference Wang X, Yang F, Xu G, Zhong S. The roles of IL-6, IL-8 and IL-10 gene polymorphisms in gastric cancer: a meta-analysis. Cytokine. 2018;111:230–6. CrossRefPubMed Wang X, Yang F, Xu G, Zhong S. The roles of IL-6, IL-8 and IL-10 gene polymorphisms in gastric cancer: a meta-analysis. Cytokine. 2018;111:230–6. CrossRefPubMed
11.
go back to reference Chen KF, Li B, Wei YG, Peng CJ. Interleukin-10 -819 promoter polymorphism associated with gastric cancer among Asians. J Int Med Res. 2010 Jan-Feb;38(1):1–8. Chen KF, Li B, Wei YG, Peng CJ. Interleukin-10 -819 promoter polymorphism associated with gastric cancer among Asians. J Int Med Res. 2010 Jan-Feb;38(1):1–8.
12.
13.
go back to reference Wu MS, Wu CY, Chen CJ, et al. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer. 2003;104(5):617–23.CrossRefPubMed Wu MS, Wu CY, Chen CJ, et al. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer. 2003;104(5):617–23.CrossRefPubMed
14.
go back to reference Savage SA, Abnet CC, Haque K, et al. Polymorphisms in interleukin– 2, -6, and– 10 are not associated with gastric cardia or esophageal cancer in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev. 2004;13(9):1547–9.CrossRefPubMed Savage SA, Abnet CC, Haque K, et al. Polymorphisms in interleukin– 2, -6, and– 10 are not associated with gastric cardia or esophageal cancer in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev. 2004;13(9):1547–9.CrossRefPubMed
15.
go back to reference Alpízar-Alpízar W, Pérez-Pérez GI, Une C, et al. Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin Exp Med. 2005;5(4):169–76.CrossRefPubMed Alpízar-Alpízar W, Pérez-Pérez GI, Une C, et al. Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin Exp Med. 2005;5(4):169–76.CrossRefPubMed
16.
go back to reference Zambon CF, Basso D, Navaglia F, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine. 2005;29(4):141–52.CrossRefPubMed Zambon CF, Basso D, Navaglia F, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine. 2005;29(4):141–52.CrossRefPubMed
17.
go back to reference Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control. 2006;17(1):117–25.CrossRefPubMed Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control. 2006;17(1):117–25.CrossRefPubMed
18.
go back to reference Sugimoto M, Furuta T, Shirai N, et al. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol. 2007;22(9):1443–9.CrossRefPubMed Sugimoto M, Furuta T, Shirai N, et al. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol. 2007;22(9):1443–9.CrossRefPubMed
19.
go back to reference Crusius JB, Canzian F, Capellá G, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol. 2008;19(11):1894–902.CrossRefPubMed Crusius JB, Canzian F, Capellá G, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol. 2008;19(11):1894–902.CrossRefPubMed
20.
go back to reference Xiao H, Jiang Y, Li R, et al. [Association of IL-10 gene polymorphisms with gastroduodenal diseases in Hubei Han population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009;26(4):423–6.PubMed Xiao H, Jiang Y, Li R, et al. [Association of IL-10 gene polymorphisms with gastroduodenal diseases in Hubei Han population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009;26(4):423–6.PubMed
21.
go back to reference Ko KP, Park SK, Cho LY, et al. Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. J Nutr. 2009;139(5):1008–12.CrossRefPubMed Ko KP, Park SK, Cho LY, et al. Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. J Nutr. 2009;139(5):1008–12.CrossRefPubMed
22.
go back to reference SU SP, Yang ZB, Tian YL, et al. Association between IL-10-819 C/C and TNF-α-1031 C/C genes and susceptibility of gastrodnodenai diseases. Chin J Microecology. 2010;22:811–5. SU SP, Yang ZB, Tian YL, et al. Association between IL-10-819 C/C and TNF-α-1031 C/C genes and susceptibility of gastrodnodenai diseases. Chin J Microecology. 2010;22:811–5.
23.
go back to reference Liu J, Song B, Wang J, et al. Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. World J Gastroenterol. 2011;17(10):1362–7.CrossRefPubMedPubMedCentral Liu J, Song B, Wang J, et al. Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. World J Gastroenterol. 2011;17(10):1362–7.CrossRefPubMedPubMedCentral
24.
go back to reference Zeng X, Li Y, Liu T, et al. Pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China. Mol Cell Biochem. 2012;362(1–2):241–8.CrossRefPubMed Zeng X, Li Y, Liu T, et al. Pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China. Mol Cell Biochem. 2012;362(1–2):241–8.CrossRefPubMed
25.
go back to reference Li L, Tang XY, Ye LM et al. Investigation on the association between IL-10 C819T gene polymorphisms and susceptibility to gastric cancer. Genet Mol Res. 2016;15(4). Li L, Tang XY, Ye LM et al. Investigation on the association between IL-10 C819T gene polymorphisms and susceptibility to gastric cancer. Genet Mol Res. 2016;15(4).
26.
go back to reference Sarah Y, Park Y, Lee J, et al. Effects of Soy Product Intake and Interleukin Genetic Polymorphisms on early gastric Cancer risk in Korea: a case-control study. Cancer Res Treat. 2017;49(4):1044–56.CrossRef Sarah Y, Park Y, Lee J, et al. Effects of Soy Product Intake and Interleukin Genetic Polymorphisms on early gastric Cancer risk in Korea: a case-control study. Cancer Res Treat. 2017;49(4):1044–56.CrossRef
27.
go back to reference Liu S, Liu JW, Sun LP, et al. Association of IL10 gene promoter polymorphisms with risks of gastric cancer and atrophic gastritis. J Int Med Res. 2018;46(12):5155–66.CrossRefPubMedPubMedCentral Liu S, Liu JW, Sun LP, et al. Association of IL10 gene promoter polymorphisms with risks of gastric cancer and atrophic gastritis. J Int Med Res. 2018;46(12):5155–66.CrossRefPubMedPubMedCentral
29.
go back to reference Steinbrink K, Jonuleit H, Müller G, et al. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood. 1999;93(5):1634–42.CrossRefPubMed Steinbrink K, Jonuleit H, Müller G, et al. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood. 1999;93(5):1634–42.CrossRefPubMed
30.
go back to reference Adris S, Klein S, Jasnis M, et al. IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response. Gene Ther. 1999;6(10):1705–12.CrossRefPubMed Adris S, Klein S, Jasnis M, et al. IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response. Gene Ther. 1999;6(10):1705–12.CrossRefPubMed
31.
go back to reference Sato T, Terai M, Tamura Y, et al. Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. Immunol Res. 2011;51(2–3):170–82.CrossRefPubMed Sato T, Terai M, Tamura Y, et al. Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. Immunol Res. 2011;51(2–3):170–82.CrossRefPubMed
Metadata
Title
The pertinence of gastric cancer and interleukin 10–819 single nucleotide polymorphisms: a meta-analysis and systematic review
Authors
Qianqian Mao
Yanwen Liu
Xi Chen
Cheng Jiang Liu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2024
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-024-03151-9

Other articles of this Issue 1/2024

BMC Gastroenterology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine